← Back to headlines
Madrigal Pharmaceuticals Reports Record 2025 Revenue
Madrigal Pharmaceuticals achieved record revenue in 2025, driven by the successful performance of its drug Rezdiffra.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
